851392-45-5

Upstream product

• 75-36-5 acetyl chloride 
• 4028-23-3 Allylchlorodimethylsilane 
• 288585-04-6 (2R,3R,4R,4aS,9aR)-3,4-Bis-(tert-butyl-dimethyl-silanyloxy)-6,6-dimethyl-2-trityloxymethyl-octahydro-1,5-dioxa-6-sila-benzocycloheptene 
• 288584-99-6 phenyl 3,4-bis-O-tert-butyldimethylsilyl-6-O-trityl-1-seleno-β-D-glucose 
• 288585-02-4 phenyl 2-O-(allyl(dimethyl)silyl)-3,4-bis-O-(tert-butyl(dimethyl)silyl)-6-O-(triphenylmethyl)-1-seleno-β-D-glucopyranoside 

Downstream Products

• 851392-49-9 Acetic acid (2R,3S,4R,5R,6R)-4,5-bis-(3-oxo-1,5-dihydro-3λ⁵-benzo[e][1,3,2]dioxaphosphepin-3-yloxy)-2-[3-(3-oxo-1,5-dihydro-3λ⁵-benzo[e][1,3,2]dioxaphosphepin-3-yloxy)-propyl]-6-trityloxymethyl-tetrahydro-pyran-3-yl ester 
• 851392-48-8 4,8-anhydro-4-O-acetyl-9-O-triphenylmethyl-2,3-dideoxy-D-glycero-D-ido-nonitol 
• 851392-47-7 4,8-anhydro-4-O-acetyl-6,7-di-O-(tert-butyl(dimethyl)silyl)-9-O-triphenylmethyl-2,3-dideoxy-D-glycero-D-ido-nonitol 

Relevant academic research and scientific papers

Synthesis of 4,8-anhydro-d-glycero-d-ido-nonanitol 1,6,7-trisphosphate as a novel IP3 receptor ligand using a stereoselective radical cyclization reaction based on a conformational restriction strategy

4,8-Anhydro-d-glycero-d-ido-nonanitol 1,6,7-trisphosphate (9), designed as a novel IP3 receptor ligand having an α-C-glycosidic structure, was synthesized via a radical cyclization reaction with a temporary connecting allylsilyl group as the ke